Dr. Ercan Elitok

Versatile expert and creative result oriented leader with passion to science and innovation – also beyond digital health.
I like complex challenges – especially the ones can be characterized with “impossible mission is a euphemism” and prefer the attitude “there is always a solution, just need to find it”.
As a physician, scientist and computer scientist I have more than 20 years of professional experience in various medical areas: Digital Health Record, Medical devices – Hardware and Software, Direct to Patient, Digital Transformation, Mobile Applications, Marketing, eCommerce, Medical IT solutions, Neuro computer science, research, clinical patient treatment and more …

My personal skills are in my job references described i.a. with overview in most difficult situations, pronounced analytical and fast thinking, systematic and result-oriented approach, high reliability, imaginativeness, consistent implementation of ideas, high ability to work under pressure and willingness to take responsibility.
Reach out to learn more about the offerings that may be helpful for you.    Contact

Languages: English - business fluent and German - like mother tongue

Present

Elucidmind Digital Health GmbH

Consultant, Interim Manager, Managing Director & Owner

2019 May

Computer-implemented method and system as well as computer program product and data structure for drawing up a nutrition plan

Publication number: 20070191689

Abstract: The present invention relates to a computer-based method, system, computer program product and data structure for drawing up a nutrition plan for at least one patient and/or a group of patients by a user comprising: a step (S1) of providing a food database (100) defining the composition of a plurality of food products composed of at least part of its food ingredients; a step (S2) of receiving an ingredient grading input by the user for establishing at least one grading for at least one food ingredient; a step (S3) of assigning the at least one grading to a food ingredient grading scheme (110); a step (S4, S4?) of applying the food ingredient grading scheme (110) to at least part of the food database (100) for achieving a grading for at least part of the food products; and a step (S5, S5?) of assigning the food ingredient grading scheme (110) and/or at least part of the graded food products (122) to the at least one patient and/or the group of patients.

Publication date: August 16, 2007

Inventor: Ercan Elitok

Stress probe for a vehicle operator

Publication number: 20050015016

Abstract: A process and system for monitoring the ability to work under pressure or receptiveness and effectiveness of a vehicle operator. The EEG-patterns of the mental activity are continuously recorded in various frequency ranges and evaluated according to various criteria. The occurrence of signals shapes or changes which indicate a impairment of operating ability are thus detected and lead, depending upon the detected status, to triggering of stepwise gradually increasing responses, from warning signals up to direct intervention and the control of the vehicle.

Publication date: January 20, 2005

Inventors: Ercan Elitok, Stefan Hahn, Wilhelm Kincses, Michael Schrauf

Method of controlling a driver assistance system and an associated apparatus
US 7710249 B2

Abstract: The present invention relates to a method of controlling a driver assistance system which can identify a danger situation with reference to a comparison of measured data with predetermined limit values and which can output a warning signal when it has identified a danger situation of this type. An additional control module is provided which determines an activity state of the driver in dependence on at least one input value which permits a conclusion on actions carried out by a driver and can suppress the outputting of the warning signal in dependence on this activity state.

Release date:  August 9, 2007

Inventors: Guenter Dobler , Ercan Elitok

Articles in Books

• Norbert Braun, Ercan Elitok, Jörg Stadler, Thomas Waller. Instrumente einer Telematik-Infrastruktur im Gesundheitswesen: Beispiele transparenter Integration über Produkt- und Institutionsgrenzen hinweg. Telemedizinführer Deutschland 2006, 7. Ausgabe (ISBN 3-9808837-9-5)

Original Articles

• Millonig A, Dressel A, Bahner D, Bitsch A, Bogumil T, Elitok E, Kitze B, Tumani H, Weber F, Gneiss C, Deisenhammer F, MxA protein--an interferon beta biomarker in primary progressive multiple sclerosis patients. Eur J Neurol. 2008 Aug;15(8):822-6. Epub 2008 Jun 28.
• Dressel A, Kolb AK, Elitok E, Bitsch A, Bogumil T, Kitze B, Tumani H, Weber, Interferon-beta1b treatment modulates cytokines in patients with primary progressive multiple sclerosis. F.Acta Neurol Scand. 2006 Dec;114(6):368-73.
• Elitok E. Mobility Applikationen der elektronischen Gesundheitsakte LifeSensor von InterComponentWare: LifeSensor Mobile, in: Eymann T, Hampe JF, Koop A, Niemann CH, Mobiles Computing in der Medizin, Proceeding zum 6. Workshop der GMDS-Arbeitsgruppe: Mobiles Computing in der Medizin (MoCoMed 2006), 02.06.2006, Frankfurt, Shaker Verlag, S. 68-75
• Uttner I, Muller S, Zinser C, Maier M, Sussmuth S, Claus A, Ostermann B, Elitok E, Ecker D, Brettschneider J, Gold R, Tumani H. Reversible impaired memory induced by pulsed methylprednisolone in patients with MS. Neurology. 2005 Jun 14; 64(11): 1971-3.
• Bitsch A, Bahner D, Wachter C, Elitok E, Bogumil T, Dressel A, Polak T, Tumani H, Weber F, Poser S, Kitze B. Interferon beta-1b modulates serum sVCAM-1 levels in primary progressive multiple sclerosis. Acta Neurol Scand. 2004 Dec;110(6):386-92.
• Yushchenko M, Mader M, Elitok E, Bitsch A, Dressel A, Tumani H, Bogumil T, Kitze B, Poser S, Weber F. Interferon-beta-1 b decreased matrix metalloproteinase-9 serum levels in primary progressive multiple sclerosis. J Neurol. 2003 Oct;250(10):1224-8.
• Brettschneider J, Ecker D, Bitsch A, Bahner D, Bogumil T, Dressel A, Elitok E, Kitze B, Poser S, Weber F, Tumani H. The macrophage activity marker sCD14 is increased in patients with multiple sclerosis and upregulated by interferon beta-1b. J Neuroimmunol. 2002 Dec;133(1-2):193-7.
• Bahner D, Klucke C, Kitze B, Elitok E, Bogumil T, Dressel A, Tumani H, Weber F, Poser S, Bitsch A. Interferon-beta-1b increases serum interleukin-12 p40 levels in primary progressive multiple sclerosis patients. Neurosci Lett. 2002 Jun;326(2):125-8.
• Lauer M, Schirrmeister H, Gerhard A, Elitok E, Beckmann H, Reske SN, Stober G. Disturbed neural circuits in a subtype of chronic catatonic schizophrenia demonstrated by F-18-FDG-PET and F-18-DOPA-PET. J Neural Transm. 2001;108(6):661-70.
• Kunstmann E, Hardt C, Elitok E, Harder M, Suerbaum S, Peitz U, Schmiegel W, Epplen JT. The Non-functional Allele TCRBV6S1B is a Risk Factor for Helicobacter pylori Infection. Infect Immun. 2000 Nov;68(11):6493-5
• Gerhard A, Neumaier B, Elitok E, Glatting G, Ries V, Tomczak R, Ludolph AC, Reske SN. In vivo imaging of activated microglia using [11C]PK11195 and positron emission tomography in patients after ischemic stroke. Neuroreport. 2000 Sept;11:2957-60
• Kunstmann E, Epplen C, Elitok E, Hader M, Suerbaum S, Peitz U, Epplen J T, Schmiegel W. Helicobacter pylori infection and polymorphisms in the tumor necrosis factor region. Electrophoresis. 1999;20:1756-61

• Elitok E, Schmid M, Karitzky J, Claus A, Neumaier B , Tomczak R, Kotzerke, J, Gerhard A, Landwehrmeyer GB, Ludolph AC, Reske SN, Schwarz J, Tumani H. ¹¹C- PK11195 - Positron Emission Tomography: An in vivo Indicator for Activated Microglia in Multiple Sclerosis – Lesions. J Neurol. 2000; 247[Suppl 3]:III/39, (ENS Jerusalem)
• Elitok E, Schmid M, Karitzky J, Claus A, Neumaier B, Tomczak R, Glatting G, Schwarz J, Ludolph AC, Reske SN, Landwehrmeyer GB, Tumani H. In vivo detection of activated microglia in patients with MS by the radio-ligand ¹¹C-PK 11195 and PET. (Conference Francois Lhermitte – 10^e Rendez-Vous de l´ARSEP ‘Molecules, cells and tissues imaging in myelin diseases’, Paris 2000)

• Elitok E, Bitsch A, Poser S, Bogumil T, Dressel A, Polak T, Tumani H, Weber F, Kitze B. Standardized tests and scales for the evaluation of coordination in primary progressive multiple sclerosis. (European Charcot Foundation Symposium ´ Scoring and Databasing in Multiple Sclerosis ´, Nice 1998)
• Elitok E, Kitze B, Bitsch A, Bahner D, Bogumil T, Dressel A, Polak T, Weber F, Rieckmann P, Poser S, Tumani H. Apo-E Serum Levels -Indicator for Disease Activity, Differentiation of Disease Subtype and Therapy Response in Multiple Sclerosis? Neurology 2000;54(7)[Suppl 3]:A349, (AAN San Diego)
• Elitok E, Glatting G, Schmid M, Tomczak R, Ludolph AC, Reske SN, Tumani H, Landwehrmeyer GB. Mikrogliaaktivierung bei Multipler Sklerose (MS) in der quantitativen¹¹C-PK 11195 (PK)-Positronenemissionstomographie (PET). Akt Neurol 2000; 27[Suppl 2]:S150, (DGN Baden-Baden)